Literature DB >> 8877186

Assessment of sequelae at home following adenotonsillectomy. A basis for day-case management?

R Benson-Mitchell1, A R Maw.   

Abstract

Adenotonsillectomy is traditionally performed as an in-patient procedure. Although day-case adenotonsillectomy is practised in some units in the USA, Canada, Finland and Israel, it is rarely practised in the UK. This study looks at a cohort of 100 consecutive children admitted for adenotonsillectomy and follows their progress after discharge. It also assesses parental attitudes to day-case surgery. The results highlight parental anxiety associated with day-case adenotonsillectomy. Only 28% of parents would have liked the procedure to be carried out on a day-case basis with 46% of parents considering a single night stay to be too short. More support must be given to parents in the UK if day-case adenotonsillectomy is to become an acceptable procedure.

Entities:  

Mesh:

Year:  1993        PMID: 8877186     DOI: 10.1111/j.1365-2273.1993.tb00848.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  4 in total

1.  Safety of day-stay tonsillectomy.

Authors:  Zahoor Ahmad; Nalaka de Silva; Randall P Morton; Andrew B A Wood
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-09-24

2.  Patients' preferences for length of stay: valuable in day-case tonsillectomy planning.

Authors:  Karin Blomgren; Yrjö Qvarnberg; Hannu Valtonen
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-17       Impact factor: 2.503

3.  [Tonsillectomy in adults: Length of hospital stay has no influence on the frequency of postoperative hemorrhage].

Authors:  A Coordes; J Soudry; V M Hofmann; M Lenarz
Journal:  HNO       Date:  2015-12       Impact factor: 1.284

4.  Prevalence of Post-tonsillectomy Bleeding as Day-case Surgery with Combination Method; Cold Dissection Tonsillectomy and Bipolar Diathermy Hemostasis.

Authors:  Abolahassan Faramarzi; Seyed Taghi Heydari
Journal:  Iran J Pediatr       Date:  2010-06       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.